239 related articles for article (PubMed ID: 28537895)
1. Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype.
Liang YJ; Wang CY; Wang IA; Chen YW; Li LT; Lin CY; Ho MY; Chou TL; Wang YH; Chiou SP; Lin YJ; Yu J
Oncotarget; 2017 Jul; 8(29):47454-47473. PubMed ID: 28537895
[TBL] [Abstract][Full Text] [Related]
2. Glycosphingolipids in human embryonic stem cells and breast cancer stem cells, and potential cancer therapy strategies based on their structures and functions.
Liang YJ
Glycoconj J; 2022 Apr; 39(2):177-195. PubMed ID: 35267131
[TBL] [Abstract][Full Text] [Related]
3. Disialyl GD2 ganglioside suppresses ICAM-1-mediated invasiveness in human breast cancer MDA-MB231 cells.
Kwon KM; Chung TW; Kwak CH; Choi HJ; Kim KW; Ha SH; Cho SH; Lee YC; Ha KT; Lee MJ; Kim CH
Int J Biol Sci; 2017; 13(3):265-275. PubMed ID: 28367091
[TBL] [Abstract][Full Text] [Related]
4. Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis.
Battula VL; Shi Y; Evans KW; Wang RY; Spaeth EL; Jacamo RO; Guerra R; Sahin AA; Marini FC; Hortobagyi G; Mani SA; Andreeff M
J Clin Invest; 2012 Jun; 122(6):2066-78. PubMed ID: 22585577
[TBL] [Abstract][Full Text] [Related]
5. Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells.
Liang YJ; Ding Y; Levery SB; Lobaton M; Handa K; Hakomori SI
Proc Natl Acad Sci U S A; 2013 Mar; 110(13):4968-73. PubMed ID: 23479608
[TBL] [Abstract][Full Text] [Related]
6. IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells.
Battula VL; Nguyen K; Sun J; Pitner MK; Yuan B; Bartholomeusz C; Hail N; Andreeff M
Oncotarget; 2017 Jun; 8(23):36936-36949. PubMed ID: 28415808
[TBL] [Abstract][Full Text] [Related]
7. TNF differentially regulates ganglioside biosynthesis and expression in breast cancer cell lines.
Dewald JH; Cavdarli S; Steenackers A; Delannoy CP; Mortuaire M; Spriet C; Noël M; Groux-Degroote S; Delannoy P
PLoS One; 2018; 13(4):e0196369. PubMed ID: 29698439
[TBL] [Abstract][Full Text] [Related]
8. GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancer.
Sarkar TR; Battula VL; Werden SJ; Vijay GV; Ramirez-Peña EQ; Taube JH; Chang JT; Miura N; Porter W; Sphyris N; Andreeff M; Mani SA
Oncogene; 2015 Jun; 34(23):2958-67. PubMed ID: 25109336
[TBL] [Abstract][Full Text] [Related]
9. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer.
Duhachek-Muggy S; Qi Y; Wise R; Alyahya L; Li H; Hodge J; Zolkiewska A
Mol Cancer; 2017 Feb; 16(1):32. PubMed ID: 28148288
[TBL] [Abstract][Full Text] [Related]
10. The biological role and immunotherapy of gangliosides and GD3 synthase in cancers.
Cao S; Hu X; Ren S; Wang Y; Shao Y; Wu K; Yang Z; Yang W; He G; Li X
Front Cell Dev Biol; 2023; 11():1076862. PubMed ID: 36824365
[TBL] [Abstract][Full Text] [Related]
11. Ganglioside GD3 synthase (GD3S), a novel cancer drug target.
Liu J; Zheng X; Pang X; Li L; Wang J; Yang C; Du G
Acta Pharm Sin B; 2018 Sep; 8(5):713-720. PubMed ID: 30245960
[TBL] [Abstract][Full Text] [Related]
12. Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2
Ly S; Anand V; El-Dana F; Nguyen K; Cai Y; Cai S; Piwnica-Worms H; Tripathy D; Sahin AA; Andreeff M; Battula VL
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33722905
[TBL] [Abstract][Full Text] [Related]
13. Hybrid clone cells derived from human breast epithelial cells and human breast cancer cells exhibit properties of cancer stem/initiating cells.
Gauck D; Keil S; Niggemann B; Zänker KS; Dittmar T
BMC Cancer; 2017 Aug; 17(1):515. PubMed ID: 28768501
[TBL] [Abstract][Full Text] [Related]
14. The ceramide moiety of disialoganglioside (GD3) is essential for GD3 recognition by the sialic acid-binding lectin SIGLEC7 on the cell surface.
Hashimoto N; Ito S; Tsuchida A; Bhuiyan RH; Okajima T; Yamamoto A; Furukawa K; Ohmi Y; Furukawa K
J Biol Chem; 2019 Jul; 294(28):10833-10845. PubMed ID: 31138648
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2.
Iwasawa T; Zhang P; Ohkawa Y; Momota H; Wakabayashi T; Ohmi Y; Bhuiyan RH; Furukawa K; Furukawa K
Int J Oncol; 2018 Apr; 52(4):1255-1266. PubMed ID: 29436609
[TBL] [Abstract][Full Text] [Related]
16. Glycolipid GD3 and GD3 synthase are key drivers for glioblastoma stem cells and tumorigenicity.
Yeh SC; Wang PY; Lou YW; Khoo KH; Hsiao M; Hsu TL; Wong CH
Proc Natl Acad Sci U S A; 2016 May; 113(20):5592-7. PubMed ID: 27143722
[TBL] [Abstract][Full Text] [Related]
17. Characterization of expression and prognostic implications of GD2 and GD3 synthase in canine histiocytic sarcoma.
Murphy JD; Axiak-Bechtel S; Milner RJ; Lejeune A; Ossiboff RJ; Gell JC; Shiomitsu K
Vet Immunol Immunopathol; 2023 May; 259():110594. PubMed ID: 37058951
[TBL] [Abstract][Full Text] [Related]
18. Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib.
Bessette DC; Tilch E; Seidens T; Quinn MC; Wiegmans AP; Shi W; Cocciardi S; McCart-Reed A; Saunus JM; Simpson PT; Grimmond SM; Lakhani SR; Khanna KK; Waddell N; Al-Ejeh F; Chenevix-Trench G
PLoS One; 2015; 10(5):e0125232. PubMed ID: 25969993
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
[TBL] [Abstract][Full Text] [Related]
20. Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells.
Kobayashi I; Takahashi F; Nurwidya F; Nara T; Hashimoto M; Murakami A; Yagishita S; Tajima K; Hidayat M; Shimada N; Suina K; Yoshioka Y; Sasaki S; Moriyama M; Moriyama H; Takahashi K
Biochem Biophys Res Commun; 2016 Apr; 473(1):125-132. PubMed ID: 26996130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
